butoxamine has been researched along with Osteoporosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, M; Asaoka, R; Goto, S; Miyazawa, K; Mizutani, Y; Sato, T; Suzuki, Y; Togari, A; Uchibori, S | 1 |
| Arai, M; Goto, S; Sato, T; Takeuchi, S; Togari, A | 1 |
2 other study(ies) available for butoxamine and Osteoporosis
| Article | Year |
|---|---|
Selective β2-adrenergic Antagonist Butoxamine Reduces Orthodontic Tooth Movement.
Topics: Acid Phosphatase; Adrenergic beta-2 Receptor Antagonists; Alveolar Process; Animals; Butoxamine; Imaging, Three-Dimensional; Isoenzymes; Male; Organ Size; Orthodontic Wires; Osteocalcin; Osteoclasts; Osteoporosis; Periodontal Ligament; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sympathetic Nervous System; Tartrate-Resistant Acid Phosphatase; Tooth Movement Techniques; Tyrosine 3-Monooxygenase; X-Ray Microtomography | 2014 |
Dose effects of butoxamine, a selective β2-adrenoceptor antagonist, on bone metabolism in spontaneously hypertensive rat.
Topics: Adrenergic beta-2 Receptor Antagonists; Animals; Biomechanical Phenomena; Blood Pressure; Body Weight; Bone and Bones; Butoxamine; Dose-Response Relationship, Drug; Lumbar Vertebrae; Male; Osteoporosis; Rats; Rats, Inbred SHR; Receptors, Adrenergic, beta-2; Sympathetic Nervous System | 2013 |